MOUSE ANTI-MCR-1/MCR-2 PROTEIN HYBRIDOMA CELL STRAIN, MONOCLONAL ANTIBODY AND USE Application EP-4265717-A4 European Patent Office 17 Apr 2024
NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETED THERAPY OF RENAL CANCERS Application WO-2023001224-A1 World Intellectual Property Organisation (WIPO) 26 Jan 2023
NOVEL COMPOUNDS AND COMPOSITION FOR TARGETED THERAPY OF KIDNEY-ASSOCIATED CANCERS Application WO-2021150792-A1 World Intellectual Property Organisation (WIPO) 29 Jul 2021